Erratum à « Efficacité du traitement topique de cyclosporine A après excision du ptérygion primaire et autogreffe conjonctivo-limbique » [J Fr Ophtalmol 2008;31(7):699–704]

Aydın, Ali Omur; Karadayı, Kürşat; Aykan, Ümit; Can, Gonul Kafali; Colakoglu, Kadir; Bilge, Aytekin

doi:10.1016/j.jfo.2010.06.006

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…also reported a low recurrence rate of 3.4% on treatment with topical CsA twice a day for 3 months following limbal conjunctival transplantation. [ 22 ] Similarly, in our study, Group C with CsA as an adjuvant had a recurrence in of 2 cases at 3 months with no complications.…”

Section: Discussionsupporting

confidence: 75%

Topical cyclosporine A and interferon alpha-2b as adjuvants to surgery to decrease pterygium recurrence

et al. 2023

View full text Add to dashboard Cite

BACKGROUND: Pterygium is very common in India and is usually removed by limbal conjunctival autograft transplantation (LCAT), which, despite being the first-line therapy, is still associated with recurrences of up to 18%. OBJECTIVES: To compare the safety and efficacy of topical cyclosporine A (CsA) and interferon (IFN) alpha-2b in the prevention of postoperative recurrence of pterygium. METHODS: A total of 40 patients with primary pterygium were randomized into two equal groups, Group C and Group I. Both the groups underwent LCAT, with Group C kept on topical cyclosporine 0.05% (CsA) 4 times daily and Group I on topical IFN alpha 2b 0.2 million IU 4 times daily postoperatively for 3 months. Pre- and posttreatment best-corrected visual acuity (BCVA), recurrence, and complications were assessed at day 1, week 1, 1 month, and 3 months. RESULTS: The mean preoperative BCVA of 0.51 ± 0.18 and 0.51 ± 0.23 improved to 0.13 ± 0.13 and 0.13 ± 0.13 in Group C and Group I, respectively, after 3 months of treatment ( P < 0.0001). Recurrence was seen in 2 cases in Group C and in 1 case in Group I at 3 months. No significant complications occurred in either of the groups. CONCLUSION: Topical CsA and IFN Alpha-2b are newer efficacious adjuvants with LCAT for prevention of postoperative pterygium recurrence.

show abstract

Section: Discussionsupporting

confidence: 75%